Alcohol, Hormones, and
Postmenopausal Women
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Many women take supplemental estrogens after menopause, a practice called hormone
replacement therapy (HRT). Moderate alcohol consumption may increase estrogen levels in
women receiving HRT, potentially affecting their risk for various adverse health effects. Two
recent studies, however, provide no strong evidence for an effect of alcohol on hormones in
postmenopausal women. The possible association between alcohol consumption and risk of
cancer of the breast does not appear to be mediated by estrogens. Both estrogens and
moderate alcohol consumption have been associated with a decreased risk for cardiovascular
disease; however, alcohol’s beneficial effect on heart disease does not appear to involve
hormonal mechanisms. Additional research is needed to define the consequences of
moderate drinking on hormone levels after menopause. KEY WORDS: AODE (alcohol and other
drug effects); menopause; female; sex hormones; estrogens; mammary gland; neoplastic
disease; cardiovascular disorder; moderate AOD use; drug therapy; literature review

pproximately 30 percent of
American women are older
than age 50, the average
age of menopause (Cramer
and Xu 1996).1 Epidemiological
studies suggest that approximately 50
percent of women in this age group
consume at least moderate quantities
of alcohol (National Institute on
Alcohol Abuse and Alcoholism
[NIAAA] 1997).2 Therefore, any
adverse effects of alcohol among this
population could have a significant
effect on public health.
Menopause is characterized by
greatly diminished levels3 of a group
of steroid reproductive hormones
called estrogens. Estrogens (e.g.,
estrone and estradiol) travel through
the bloodstream and exert widespread
physiological effects on organ growth
and development. Approximately 25
percent of postmenopausal women take
supplemental estrogens to alleviate
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unpleasant symptoms of menopause,
a practice called hormone replacement
therapy (HRT) (Ginsburg et al. 1996).
Estrogens have various effects on the
health of postmenopausal women
(Rich-Edwards and Hennekens 1996).
For example, HRT decreases the risk
of cardiovascular disease and osteoporosis4 but may increase the risk of
breast cancer (Ginsburg et al. 1996).
Recent experimental studies show
that moderate alcohol consumption
may increase estrogen levels in postmenopausal women receiving HRT
(Ginsburg et al. 1996).
This article reviews some of the
basic hormonal changes associated
with menopause, examines the effects
of alcohol consumption on estrogen
levels after menopause, and discusses
the relationship of postmenopausal
alcohol use to the risks of cardio
vascular disease and cancer. Although
several reproductive hormones may

play important roles in the menopausal transition, this article focuses
on estrogens, in part because the health
effects of altered estrogen levels are
relatively well understood. For a discussion of alcohol’s effects on postmenopausal women with alcoholic
cirrhosis, see Gavaler (1995).
1

The article cited defines menopause as the
absence of menstrual periods for 1 year (Cramer
and Xu 1996).
2

Although definitions of moderate drinking vary
widely, an upper limit of two standard drinks per
day for men and one for women is often employed.
A standard drink is equivalent to 12 ounces of
beer, 5 ounces of wine, or 1.5 ounces of 80-proof
spirits (NIAAA 1992).
3

Unless otherwise specified, this article uses the
term “level(s)” to refer to the concentrations of
a given substance in the blood.
4

Osteoporosis is a bone disorder that commonly
occurs in postmenopausal women (see article by
Sampson and colleagues, pp. 190–194).
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Hormonal Function
Before Menopause
The female reproductive cycle is
governed primarily by two groups
of hormones: the gonadotropins and
the steroid reproductive hormones.
The gonadotropins include folliclestimulating hormone (FSH) and
luteinizing hormone (LH), which are
produced by the pituitary gland and
released into the bloodstream. The
steroid reproductive hormones are pro
duced largely in the ovaries. Approx
imately every 28 days, levels of FSH
and LH in the blood begin to increase,
stimulating the growth and develop
ment of specialized cell clusters (i.e.,
follicles) within the ovaries. Each
follicle nurtures a developing egg
cell (i.e., ovum) and secretes estrogens.
Within the ovaries, estrogens help
promote follicular development. A
midcycle surge of LH secretion from
the pituitary gland causes the release
of a mature ovum, which then migrates
away from the ovaries. Under the
influence of LH, the ovary continues
to secrete estrogens and other steroid
hormones to prepare the body for
pregnancy and lactation. If the ovum
is not fertilized, gonadotropin and
ovarian hormone levels decline until
the next cycle is about to begin.
These cyclic events are orchestrated
by complex interactions among
many hormones and other physiolog
ical substances. For example, the ovaries
release hormones called activin and
inhibin, which, respectively, stimulate
and suppress gonadotropin produc
tion. In addition, the pituitary gland
adjusts the magnitude and timing of
gonadotropin secretion in response
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to levels of ovarian hormones in the
blood. This mechanism, called feed
back regulation, helps fine tune
hormone levels and promotes the
orderly progression of physiological
events. Hormonal balance also is
influenced by metabolic reactions
that can synthesize specific hormones
from other hormones to which they
are structurally related.

Hormonal Changes
During Menopause
The number of functional ovarian fol
licles decreases with age. This decrease
accelerates after approximately age 40
(Burger 1996a); thus, by the time a
woman experiences her final men
strual period (i.e., menopause), the
ovaries contain virtually no follicles
(Burger 1996b). The postmenopausal
state is characterized by unvarying
hormone levels and the absence of
ovulatory cycling.
The approach of menopause is
signaled by a transitional period that
begins with a break in the regular
pattern of ovarian cycling. During
the transitional phase, which lasts
approximately 4 years, hormone
levels fluctuate widely. In particular,
FSH levels sometimes increase signif
icantly, even in the presence of normal
ovarian function and without an
accompanying decrease in estradiol
levels (Metcalf et al. 1981). Although
overall levels of estradiol and inhibin
change relatively little during the
transitional phase (Korenman et al.
1978; Burger 1996b), subtle declines
in their levels may contribute to
the progressive elevation of FSH to
consistently high postmenopausal
levels (see next section of this article)
(Burger 1996b).

Hormones in
Postmenopausal Women
Despite the absence of ovarian folli
cles, estrogen production continues
after menopause, albeit at reduced
levels. Postmenopausal estrogens are
synthesized from a class of steroid

hormones called androgens (e.g.,
testosterone and androstenedione). In
men, androgens are the primary repro
ductive hormones, produced mainly
in the testes. In women, androgens
are produced in the ovaries and in
the adrenal glands and are carried
through the bloodstream to body fat,
where androstenedione is converted
to estrone (Korenman et al. 1978).
After menopause, estrone replaces
estradiol as the primary estrogen
(Korenman et al. 1978). Postmeno
pausal estradiol levels are greatly
reduced and are derived from the
metabolism of estrone (Korenman et
al. 1978; Burger 1996a).
Levels of testosterone and ovarian
androstenedione also decrease after
menopause, although adrenal andro
stenedione levels remain unchanged
until later in life (Burger 1996a).
Inhibin levels become undetectable
after menopause (Burger 1996b).
Released from the feedback regulation
formerly provided by changing levels
of ovarian hormones, levels of FSH
increase up to 15 times compared with
premenopausal levels, and LH levels
increase up to 3 times (Burger 1996b);
the significance of these increases in
the absence of ovarian follicles is
probably minimal.

Alcohol and Estrogen
Levels
Studies of alcohol’s effects on post
menopausal women generally focus
on estradiol because of its greater
potency compared with estrone.
However, the low levels of estradiol
after menopause are difficult to mea
sure accurately (Carlstrom 1996).
Methods for quantifying steroids
differ in sensitivity and specificity,
a factor that may contribute to the
discrepancies in analytical results
among studies (Gavaler et al. 1991;
Cauley et al. 1989).
In one study, a single large dose
of alcohol (42 to 46 grams, equivalent
to approximately 3.5 to 4 standard
drinks) caused a temporary increase
in estradiol levels in postmenopausal
women receiving HRT (Ginsburg et
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levels in those studies. Findings for
estradiol were mixed among women
not on HRT, with some studies show
ing a direct association between
alcohol consumption and estradiol
levels and some not. In contrast to
the results summarized in table 1,
nonexperimental data on women
receiving HRT (Johannes et al. 1997)
found lower levels of estradiol among
women who consume higher levels
of alcohol (table 2).
Additional data suggest that alco
hol consumption after menopause is
unrelated to levels of androstenedione,
(Cauley et al. 1989), testosterone
(Cauley et al. 1989; Newcomb et al.
1995), or sex hormone-binding
globulin, a specialized protein that
facilitates the transport of androgens
through the bloodstream (Newcomb
et al. 1995; Nagata et al. 1997). How
ever, two of three studies demonstrated
an association between alcohol con
sumption and levels of a specific

al. 1995, 1996) (see table 1), possibly
by inhibiting the conversion of estra
diol to estrone. However, alcohol
administration had no effect on hor
mone levels in women who were not
receiving HRT. This result is consis
tent with an earlier finding that
alcohol administration under similar
conditions had no effect on LH levels
in postmenopausal women regardless
of HRT use (Mendelson et al. 1985).
In addition, alcohol administration
had no effect on estrone levels in
either group of women. The effects of
lower doses or prolonged administra
tion of alcohol have not been studied
experimentally.
In nonexperimental studies,
researchers have compiled epidemio
logical data to investigate possible
associations between self-reported
alcohol consumption and hormone
levels among postmenopausal women
(see table 2). Alcohol consumption
was consistently unrelated to estrone
Table 1

steroid substance that serves as an
intermediary for the synthesis of
androstenedione (Nagata et al.
1997; Barret-Conner and GoodmanGruen 1995; Newcomb et al. 1995).
The only study that examined alco
hol’s effects on estrone sulfate found
a positive association between alco
hol consumption and estrone sul
fate levels (Hankinson et al. 1995).
Together, these data suggest that
alcohol may affect hormones other
than the major estrogens. However,
confirmations of those associations
are needed before any firm conclusions
can be drawn.
The epidemiological studies
described above address only the
overall association between alcohol
consumption and hormone levels.
Little information is available on
specific factors that might modify
or contribute to alcohol’s effects.
Those factors might include drinking
patterns, including timing, frequency,

Effect of a Single Dose of Alcohol on Estrogen Levels in the Blood of Postmenopausal Women
Result

Author

n

Ginsburg et al. 1995
Ginsburg et al. 1996

Ethanol Dose (g)

7
12
12

46
42
42

E1

E2

no change
no change
no change

increased
increased
no change

Subjects on Hormone Replacement Therapy
yes
yes
no

NOTE: n = number of subjects; g = grams; E1 = estrone; E2 = estradiol.

Table 2

The Relation of Alcohol Consumption to Estrogen Levels in the Blood of Postmenopausal Women
Result

Author
Cauley et al. 1989
Newcomb et al. 1995
Hankinson et al. 1995
Johannes et al. 1997

Gavaler et al. 1991
Nagata et al. 1997

n

E1

E2

1761
253
217
148
53
92
244
61

no change
no change
no change
no change
no change
no change
—
—

no change
—
no change
no change
no change
decreased
increased 2
increased

Subjects on Hormone Replacement Therapy
past or never
never
past or never
past
never
yes
past or never
past or never

NOTE: n = number of subjects; E1 = estrone; E2 = estradiol; — = not measured or data not given.
1
Note that 128 of the subjects were in the Pittsburgh subgroup of Gavaler et al. 1991.
2
E2 increased in subjects from three of four cities studied.
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and quantity of consumption; the time
that has elapsed between a subject’s
last drink and the determination of her
hormone levels; and alcohol’s ultimate
effects on the tissue responses induced
by specific hormones. Additional data
also are needed on the effects of alco
hol on the adrenal steroid hormone
precursors of estrogens and on estrone
sulfate. In addition, most of the sub
jects in the studies cited who con
sumed alcohol were light or moderate
drinkers (i.e., consuming approxi
mately two to four drinks per week);
thus, the available data provide little
information about the effect of heavy
drinking. Results also are subject to
errors in the estimation of alcohol
consumption and imprecision in the
determination of hormone levels.
Overall, the data in tables 1 and 2
are consistent with the hypothesis that
light or moderate alcohol consump
tion does not affect estrone levels. In
addition, although data from some
nonexperimental studies have linked
alcohol consumption with higher levels
of other steroid hormones in post
menopausal women (e.g., estradiol
and estrone sulfate), the evidence that
alcohol affects the levels of those hor
mones is inconclusive.

Alcohol, Hormones,
and Cancer
Cancer of the breast is among the
most common fatal cancers among
women in the United States. Annually,
approximately 180,000 women are
diagnosed with breast cancer, and
44,000 women die of the disease (Chu
et al. 1996). Evidence suggests that
alcohol consumption may be associated
with increased risk for this cancer,
although whether this association is
causal remains unresolved (Longnecker
1992). The lack of strong evidence for
alcohol-induced changes in estrogen
levels either before or after menopause
suggests that effects of alcohol in
breast cancer may involve nonhor
monal mechanisms. This conclusion
is supported by evidence suggesting
that alcohol consumption is not a risk
factor for cancer of the glandular
188

internal lining of the uterus (i.e.,
endometrial cancer), which is known
to be hormone related (Rich-Edwards
and Hennekens 1996). In the mam
mary glands of rats, alcohol caused
tissue changes thought to be associ
ated with increased risk for cancer
without affecting estrogen levels
(Singletary 1997).

Alcohol, Hormones,
and Heart Disease
Among women, consumption of
at least one standard drink per day
is associated with approximately a
20-percent reduction in risk of
cardiovascular disease compared with
nondrinkers (Thun et al. 1997).
Although the nature of this relation
ship is the subject of continuing
debate (Lowenfels 1998), evidence
shows that moderate alcohol consump
tion ameliorates known risk factors
for cardiovascular disease, including
specific measures of blood chemistry
and the clotting response (Freedman
et al. 1992; Kannel and Ellison 1996).
Estrogens have a beneficial effect on
risk for cardiovascular disease, and
most cardiovascular disease in women
occurs after menopause, when estro
gen levels are low (Witteman et al.
1998). Lack of a clear effect of alcohol
on estrogens in postmenopausal women,
however, does not preclude a causal
relation between light and moderate
intake and decreased risk of cardiovas
cular disease. (See the article by
Gavaler on pp. 220–227 for another
view on this topic.)

Summary
The complete loss of ovarian follicles
among middle-aged women is nor
mal, and after menopause, estrogen
levels are low. In general, the few
studies available provide no strong
evidence for an effect of alcohol on
hormones in postmenopausal women.
In addition, the possible association
between alcohol consumption and
risk of breast cancer does not appear
to be mediated by estrogens. Evidence

supports an association between mod
erate alcohol consumption and a
decreased risk of cardiovascular disease,
and this effect may be independent
of hormonal influence. More data
are needed to confirm these findings
and to clarify the roles and relative
importance of alcohol both during
and after menopause on hormones
other than estrogens. ■
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How effective is brief intervention for helping patients
to reduce or stop drinking?
What strategies can be used in the workplace to prevent
and reduce alcohol-related problems?

T

he answers to these and other questions can be found in Alcohol Alert, the quarterly bulletin published
by the National Institute on Alcohol Abuse and Alcoholism. Alcohol Alert provides timely information
on alcohol research and treatment. Each issue addresses a specific topic in alcohol research and
summarizes critical findings in a brief, four-page, easy-to-read format. Our most recent issue — Brief
Intervention for Alcohol Problems (No. 43)—explains the components of brief intervention and considers
the effectiveness of this approach.

Forthcoming issues include the following:
•

Alcohol and the Workplace (No. 44), which discusses recent research on the effects of
employee drinking, workplace alcohol policies, and workplace-based programs for
preventing and reducing alcohol-related problems.

For a free subscription to Alcohol Alert, write to: National Institute on Alcohol Abuse and Alcoholism,
Attn.: Alcohol Alert, Publications Distribution Center, P.O. Box 10686, Rockville, MD 20849–0686. Fax: (202) 842–0418.
Alcohol Alert is available on the World Wide Web at http://www.niaaa.nih.gov
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